SJ, C., T, Y., GR, W., FL, S., H, X., Z, Z., & B, R. (2025). The efficacy and safety of denosumab, risedronate, alendronate and teriparatide to treat male osteoporosis: A systematic review and bayesian network meta-analysis. Frontiers in endocrinology, 16, 1579101. https://doi.org/10.3389/fendo.2025.1579101
Chicago Style (17th ed.) CitationSJ, Chai, Yu T, Wang GR, Sun FL, Xue H, Zhang Z, and Ran B. "The Efficacy and Safety of Denosumab, Risedronate, Alendronate and Teriparatide to Treat Male Osteoporosis: A Systematic Review and Bayesian Network Meta-analysis." Frontiers in Endocrinology 16 (2025): 1579101. https://doi.org/10.3389/fendo.2025.1579101.
MLA (9th ed.) CitationSJ, Chai, et al. "The Efficacy and Safety of Denosumab, Risedronate, Alendronate and Teriparatide to Treat Male Osteoporosis: A Systematic Review and Bayesian Network Meta-analysis." Frontiers in Endocrinology, vol. 16, 2025, p. 1579101, https://doi.org/10.3389/fendo.2025.1579101.
